Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Physiol.

Sec. Clinical and Translational Physiology

The domestic pig as a translational model of hyperoxaluria: a pilot study of acute and chronic sodium oxalate infusion

Provisionally accepted
Tomasz  JacekTomasz Jacek1*Dominika  SzkopekDominika Szkopek2Piotr  WychowanskiPiotr Wychowanski3,4Janine  DonaldsonJanine Donaldson5Kamil  ZaworskiKamil Zaworski6Mariusz  StrutyńskiMariusz Strutyński7Siarhei  KirkoSiarhei Kirko7Olena  PrykhodkoOlena Prykhodko8,9Olexandr  FedkivOlexandr Fedkiv8,9Stefan  G PierzynowskiStefan G Pierzynowski10,7,8Kateryna  PierzynowskaKateryna Pierzynowska6,7,8*
  • 1Instytut Zootechniki Panstwowy Instytut Badawczy, Kraków, Poland
  • 2Large Animal Models Laboratory, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Jabłonna, Poland
  • 3Catholic University of the “Sacred Heart”, Department of Head and Neck and Sensory Organs, Rome, Italy
  • 4Department of Interventional Dentistry, Collegium Medicum, Nicolaus Copernicus University,, Bydgoszcz, Poland
  • 5Department of Physiology, School of Biomedical Sciences, Faculty of Health Sciences, University of the Witwatersrand,, Johannesburg, South Africa
  • 6Department of Animal Physiology, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, Jabłonna, Poland
  • 7Anara AB, Trelleborg, Sweden
  • 8Department of Biology, Lund University, Lund, Sweden
  • 9Division of Food and Pharma, Department of Process and Life Science Engineering, Lund University, Lund, Sweden
  • 10Department of Medical Biology, Institute of Rural Health, Lublin, Poland

The final, formatted version of the article will be published soon.

The purpose of this pilot study was to develop and characterize an in vivo porcine model of hyperoxaluria using intravenous infusion of sodium oxalate (NaOx). 2 experimental regimens were developed to replicate acute and follow up chronic hyperoxaluria. In the acute model, 3 different doses of 1% NaOx were administered over 15 hours, resulting in a dose-dependent increase in plasma oxalate concentration (Cmax: 42.4-122.4 µM) and transient hyperoxaluria, with a return to baseline values 6-8 hours after stopping the infusion of NaOx solution. In the chronic model, repeated infusions of NaOx for 7-11 days directly after acute tests led to persistent hyperoxalemia (up to 302.4 µM), clinical deterioration and dose-dependent calcium oxalate (CaOx) deposits in renal tissue (1.85%-9.55% of renal surface area), consistent with impaired renal function. The model represents the key clinical features of both rapidly inducible and reversible hyperoxalemia and hyperoxaluria, as well as the progressive nephrocalcinosis. Due to the physiological similarity between pigs and humans, the proposed porcine model could be considered as a quick and valuable tool for studying the pathophysiology of oxalate excess and testing the efficacy of new therapies to counteract its toxicity.

Keywords: Calcium Oxalate, Hyperoxalemia, Hyperoxaluria, Nephrolithiasis, pig model, Sodium oxalate

Received: 25 Aug 2025; Accepted: 15 Dec 2025.

Copyright: © 2025 Jacek, Szkopek, Wychowanski, Donaldson, Zaworski, Strutyński, Kirko, Prykhodko, Fedkiv, Pierzynowski and Pierzynowska. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Tomasz Jacek
Kateryna Pierzynowska

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.